WFA
ONC

Wipfli Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Wipfli Financial Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Buy
+1
New +$172 ﹤0.01% 2627

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Wipfli Financial Advisors's ONC Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in BeOne Medicines Ltd (ONC) in Q3 2022: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2627 among its holdings.

222 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

  • Wipfli Financial Advisors held 1 share of BeOne Medicines Ltd worth $0 as of Q3 2022.
  • BeOne Medicines Ltd was a new Wipfli Financial Advisors position in Q3 2022.
  • BeOne Medicines Ltd made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2627 holding.
  • 222 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.